Vanda Pharmaceuticals earnings were -$44.2M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest VNDA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$29.5M, up 500.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VNDA reported annual earnings of -$18.9M, with -853.3% growth. The next VNDA earnings date is Jul 29, 2025.
Vanda Pharmaceuticals Earnings Reports & History FAQ
What were Vanda Pharmaceuticals's earnings last quarter?
On VNDA's earnings call on Invalid Date, Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 2025 earnings per share (EPS) of -$0.50, up 614.29% year over year. Total VNDA earnings for the quarter were -$29.49 million. In the same quarter last year, Vanda Pharmaceuticals's earnings per share (EPS) was -$0.07.
The next VNDA earnings call is Invalid Date. Add VNDA to your watchlist to be reminded of Vanda Pharmaceuticals's next earnings date.
What was VNDA's earnings growth in the past year?
As of Vanda Pharmaceuticals's earnings date in Invalid Date, Vanda Pharmaceuticals's earnings has grown year over year. VNDA earnings in the past year totalled -$44.25 million.
Is Vanda Pharmaceuticals profitable or losing money?
As of the last Vanda Pharmaceuticals earnings report, Vanda Pharmaceuticals is currently losing money. Vanda Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$44.25 million, a 805.05% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.